The impact of climate and demographic changes on future chikungunya burden and the potential role of vaccines: a mathematical modelling study
Cortes-Azuero, O.; Finch, E.; Ribeiro dos Santos, G.; Sutcliffe, E.; Scarponi, D.; Ryan, S. J.; Salje, H.
Show abstract
BackgroundChikungunya virus (CHIKV) is an Aedes transmitted arbovirus. Demographic changes coupled with the expanding footprint of the mosquito from climate change have the potential to shift the global burden from the virus. MethodsHere we use projections of human demography and Aedes mosquitoes distribution to estimate baseline and future burden from CHIKV under different climate change scenarios in 178 countries. We then estimate the potential of vaccines to mitigate the growing burden. FindingsWe found that under RCP2.6 (an optimistic climate change scenario), the global population at risk from CHIKV will increase by 30.2% to 5.4 billion individuals. We estimated a 35% increase in annual infections, 49% increase in cases and a 128% increase in deaths. A similar impact was found under the more pessimistic RCP8.5 climate change scenario. In Europe and the Americas, the growing presence of Aedes will drive the growing case burden, with increases in human population size being key elsewhere. Ageing populations will result in major increases in the number of CHIKV-related deaths in all continents outside Africa. Vaccinating 50% of individuals aged 12y+ with a vaccine providing 70% protection against disease and 40% protection against infection would avert 29% of cases and 31% of deaths. InterpretationThese findings highlight how climate change will expand the footprint of CHIKV circulation, while demographic changes will lead to substantially increased case burden in affected countries. Vaccines will be critical to minimising this changing global burden. FundingCEPI
Matching journals
The top 7 journals account for 50% of the predicted probability mass.
Similar papers in this journal
Similar papers in this journal
- The global landscape of susceptibility to orthopoxviruses: The legacy of smallpox vaccination 95%
- Estimating the impact of the w Mel release program on dengue and chikungunya incidence in Rio de Janeiro, Brazil 94%
- Prioritising COVID-19 vaccination in changing social and epidemiological landscapes 90%
Similar papers in this journal
- Impact of COVID-19-related disruptions to measles, meningococcal A, and yellow fever vaccination in 10 countries 95%
- SARS-CoV-2 transmission dynamics in South Africa and epidemiological characteristics of the Omicron variant 94%
- Integrating contact tracing and whole-genome sequencing to track the elimination of dog-mediated rabies 93%
Similar papers in this journal
- Informing an investment case for Japanese encephalitis vaccine introduction in Bangladesh 94%
- Burden is in the eye of the beholder: Sensitivity of yellow fever disease burden estimates to modeling assumptions 93%
- Resurgence of SARS-CoV-2 in India: Potential role of the B.1.617.2 (Delta) variant and delayed interventions 92%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.